Centiva Capital, LP Biogen Inc. Call Options Transaction History

Centiva Capital, LP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $1.04 Million - $1.17 Million	4,100 New	4,100 $1.05 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $631,100 - $766,800	-2,500 Reduced 44.64%	3,100 $858,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $1.38 Million - $1.91 Million	-7,100 Reduced 55.91%	5,600 $1.5 Million
Q2 2022 Aug 17, 2022	SELL	$187.54 - $223.02 $2.57 Million - $3.06 Million	-13,700 Reduced 51.89%	12,700 $2.59 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $3 Million - $3.78 Million	15,500 Added 142.2%	26,400 $5.56 Million

Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $156,744 - $201,439	700 Added 6.86%	10,900 $2.62 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $537,700 - $682,080	2,000 Added 24.39%	10,200 $3.23 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $1.14 Million - $1.58 Million	5,200 Added 173.33%	8,200 $2.43 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $219,290 - $241,720	-1,000 Reduced 25.0%	3,000 $702,000
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $758,485 - $1.19 Million	-3,500 Reduced 46.67%	4,000 $945,000
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $1.14 Million - $1.45 Million	4,100 Added 120.59%	7,500 $2.26 Million
Q2 2018 Aug 03, 2018	BUY	$257.52 - $306.91 $875,567 - $1.04 Million	3,400 New	3,400 $986,000

1,047

126M

1.37M

1.35M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.